A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B
2006; Massachusetts Medical Society; Volume: 354; Issue: 10 Linguagem: Inglês
10.1056/nejmoa051285
ISSN1533-4406
AutoresTing‐Tsung Chang, Robert G. Gish, Robert de Man, Adrián Gadano, Jose D. Sollano, You‐Chen Chao, Anna S. Lok, Kwang–Hyub Han, Zachary Goodman, Jin Zhu, Anne Cross, Deborah DeHertogh, Richard B. Wilber, Richard J. Colonno, David Apelian,
Tópico(s)Liver Disease Diagnosis and Treatment
ResumoEntecavir is a potent and selective guanosine analogue with significant activity against hepatitis B virus (HBV).
Referência(s)